This CBD stock could potentially generate 716.8%
Profit in no time...
June
10, 2019 -- InvestorsHub NewsWire -- If you don't know, consumers
just celebrated the largest cannabis holiday on April 20th. Now,
this holiday may have increased earnings for various cannabis
companies, as well as cannabidiol (CBD) companies. However, with
CBD - it's different.
You see, CBD is non-psychoactive and helps provide pain relief, as
well as treat various symptoms.
Consequently,
CBD is becoming widely accepted by consumers and countries. For
example, in the U.S., CBD became legal after the Farm Bill that
passed in late
2018.
That
in mind, consumers could easily find CBD products across the U.S.
In turn, we may actually
see some CBD
companies generating more revenues and earnings than cannabis
companies.
Now,
Bethany Gomez, a researcher for The Brightfield
Group
estimate that the CBD market will reach $22B by 2022. What's
even more positive is Europe is just starting to get into the game
and
our next pick is a first-mover in the European CBD
Market.
That
said, CBD companies could experience exponential growth rates with
such a large market. Not only that, large-cap drug
stores like CVS and Walgreens have bet on CBD.
Additionally,
CVS and Walgreens noted they would offer CBD products in more than
2,000 stores across the U.S.
But
these companies need to find a reputable source for CBD products.
Now, this one
little-known company focused on CBD
has figured out how to
create CBD Isolate for $744 per kg. Their first
crop is due in August 2019 and expected to produce 16,000 kg of CBD
Isolate. The current U.S. wholesale price for CBD Isolate is
$6,077 per kg.
That would be a 716.8% Profit Margin!
With
CVS and Walgreens offering CBD products, it wouldn't be surprising
to see either of these two large drug store companies to strike a
partnership with this CBD company.
Here are four major reasons why this
CBD company
could break out BIG:
-
Massive
3,706
acre Hemp farm in
Poland scheduled to have its first crop in
August
-
With
a production output estimated at 16,000 kg in 2019, forecasted
revenue can be expected to be an impressive $97.23 million and $197
million in 2020.
-
Raised CAD
$24.36 in April,
2019
-
An extraction contract with DragonFly Biosciences, Europe's largest
CBD
retailer, is worth $48 million over the next three
years.
It seems like this company's future is unstoppable. Who can
compete with them to produce at these levels? We haven't
found one yet…
It's always fun to share a secret like this with investors
like
you, but the word may get out quickly and the stock may not sit at
these levels for long.
Get the full meal deal here.